Aspen Neuroscience, Inc., a clinical?stage biotechnology company pioneering autologous regenerative therapies, today announced two executive leadership appointments: Revati Shreeniwas, M.D., FCCP has ...

Cuin Immigration has released a detailed FAQ addressing key concerns of prospective clients regarding the legitimacy, processing times, and secure payment methods associated with Canadian immigration ...

The 5th iPSC Drug Development Summit serves as a pivotal platform for uniting iPSC-based drug developers across the value chain, from research and development through to CMC, to accelerate the ...

Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases and cancer, today announced ...

What Changed in the Price Target Narrative Analysts lifting their Prothena price target to US$36, from US$15, are tying that view to how they see the partnered pipeline converting into future royalty ...

Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician (CMT). Basic earnings per share (EPS) tells investors how much of a firm's net income ...

Whether you’re a seasoned fashion vet or rolling up fresh-faced to the menswear table, basics are the foundation of every great wardrobe. Yes, the best men's clothing brands are paid to push things ...

Correspondence to Professor Peter B O'Sullivan, School of Physiotherapy and Exercise Science, Curtin University, Perth, WA 6102, Australia; p.osullivan{at}curtin.edu.au If you wish to reuse any or all ...

Sinus node dysfunction (SND) is a prevalent arrhythmia syndrome characterized by sinoatrial node pacemaker failure. This study engineers stem cell-derived vesicles with platelet membranes for targeted ...

Basic Allowance for Subsistence (BAS) pays for the cost of a military member's meals when dining at their permanent duty station. Although BAS is meant to offset the cost of a member's meals, it doesn ...

Chocolate or strawberry? Life or death? We make some choices quickly and automatically, relying on mental shortcuts our brains have developed over the years to guide us in the best course of action.

Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced ...